This page shows the latest Antiretroviral therapy news and features for those working in and with pharma, biotech and healthcare.
The PrEP Impact Trial is using Mylan's generic version of Gilead Sciences’ antiretroviral therapy Truvada (emtricitabine/tenofovir disoproxil) but is due to come to an end in October.
suppression prior to starting antiretroviral therapy (ART). ... Stem cell transplants are high-risk procedures, so the treatment wouldn’t be suitable as a routine therapy for HIV-positive people.
ATLAS involved pateints who had been previously treated with long-acting antiretroviral therapy (ART), and showed that the combination injection matched standard therapy on viral suppression rates. ... Three patients treated with ViiV’s injectable (1%)
ViiV already have another two-in-one STR, Juluca (dolutegravir/rilpivirine), but this is only approved for HIV patients who have achieved viral suppression with another antiretroviral therapy. ... The HIV therapy market is also likely to be affected by
The long-acting antiretroviral therapy (ART) could mean that more patients adhere to the treatment regimen needed to suppress HIV, and avoid the risk of skipped doses that can help viral ... If approved, this two-drug regimen would give people living
Moreover, patients in a control arm receiving standard oral antiretroviral therapy (ART) who elected to swap over to the injectable regimen after 96 weeks did so without loss of viral suppression, ... combinations GSK is hoping will simplify HIV therapy
More from news
Approximately 1 fully matching, plus 42 partially matching documents found.
This type of combination therapy is known as highly active antiretroviral therapy (HAART), and remains the recommended treatment for HIV today. ... Ipsos' HIV Therapy Monitor data shows that the top reason for prescribing an STR is convenience.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
low level of education. culture. lay beliefs. THERAPY-RELATED FACTORS. complexity of regimen. ... How well do. clinicians estimate patients’ adherence to combination antiretroviral therapy?
While the advances in antiretroviral therapy (ART) have transformed the prognosis for a whole patient cohort, the role and sense of self of HIV specialists has undeniably changed, which in turn
Whilst not new, this approach is becoming increasingly effective for certain therapy areas, particularly oncology. ... Another popular combination therapy is HAART: Highly Active Antiretroviral Therapy used for HIV where six major types of drugs
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...